跳至主要内容
临床试验/NL-OMON50635
NL-OMON50635招募中不适用

Maastricht IBS Cohort: Phenotypical and genotypical characterization of patients with Irritable Bowel Syndrome - Maastricht IBS Cohort

Interne Geneeskunde0 个研究点目标入组 1,400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • IBS patients:
  • 1) IBS will be diagnosed according to the Rome III criteria:
  • Recurrent abdominal pain or discomfort at least 3 days per month in the last 3
  • months associated with 2 or more of the following:
  • * Improvement with defecation
  • * Onset associated with a change in frequency of stool
  • * Onset associated with a change in form (appearance) of stool
  • 2) Based on the medical history and previous examination, no other causes for
  • the abdominal complaints can be defined. , Healthy controls:
  • 1) Age between 18 and 75 years

排除标准

  • IBS patients:
  • 1) Abdominal surgery, except for uncomplicated appendectomy, laparoscopic
  • cholecystectomy or hysterectomy. , Healthy controls:
  • 1) Gastrointestinal disorders (current or in medical history) or current
  • gastrointestinal complaints.
  • 2) Abdominal surgery, except for uncomplicated appendectomy, laparoscopic
  • cholecystectomy or hysterectomy.
  • 3) Use of medication that can influence gastrointestinal motility or perception
  • (like loperamide, butylscopolamine, psylliumsead (metamucil), duspatal,
  • metoclopramide, domperidon, erytromycine and serotonin reuptake inhibitors),
  • for at least 3 months before tests.

研究者

发起方
Interne Geneeskunde

相似试验